Tweet
B. Riley set a $2.00 target price on Aemetis (NASDAQ:AMTX) in a research report sent to investors on Monday. The brokerage currently has a hold rating on the specialty chemicals company's stock. B. Riley also issued estimates for Aemetis' Q3 2018 earnings at ($0.31) EPS, Q4 2018 earnings at ($0.31) EPS, FY2018 earnings at ($1.40) EPS, Q1 2019 earnings at ($0.30) EPS, Q2 2019 earnings at ($0.26) EPS, Q3 2019 earnings at ($0.27) EPS, Q4 2019 earnings at ($0.22) EPS and FY2019 earnings at ($1.04) EPS.
Separately, Zacks Investment Research raised Aemetis from a sell rating to a hold rating in a research note on Monday, July 16th. Get Aemetis alerts:
AMTX stock opened at $1.20 on Monday. Aemetis has a 1 year low of $0.45 and a 1 year high of $3.12. The company has a debt-to-equity ratio of -1.53, a current ratio of 0.27 and a quick ratio of 0.11. Aemetis (NASDAQ:AMTX) last posted its earnings results on Thursday, August 9th. The specialty chemicals company reported ($0.27) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.34) by $0.07. equities analysts predict that Aemetis will post -1.61 earnings per share for the current fiscal year.
Aemetis Company Profile
Aemetis, Inc operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced bio refineries